 Catherine Flaitz
Concepts (788)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dental Caries | 58 | 2017 | 173 | 4.190 |
Why?
| | Mouth Diseases | 21 | 2018 | 47 | 2.790 |
Why?
| | Mouth Neoplasms | 23 | 2012 | 90 | 2.050 |
Why?
| | Diagnosis, Differential | 61 | 2025 | 1508 | 2.020 |
Why?
| | Cariostatic Agents | 23 | 2014 | 32 | 1.960 |
Why?
| | Dental Cementum | 4 | 2025 | 11 | 1.870 |
Why?
| | Fluorides | 23 | 2014 | 49 | 1.750 |
Why?
| | Gingival Diseases | 12 | 2012 | 19 | 1.630 |
Why?
| | Dental Enamel | 32 | 2007 | 67 | 1.540 |
Why?
| | Mouth Mucosa | 21 | 2014 | 85 | 1.280 |
Why?
| | Tongue Neoplasms | 5 | 2013 | 25 | 1.260 |
Why?
| | Dental Restoration, Permanent | 12 | 2003 | 43 | 1.170 |
Why?
| | Incisor | 5 | 2025 | 22 | 1.160 |
Why?
| | Mandibular Neoplasms | 13 | 2003 | 22 | 1.030 |
Why?
| | Tooth Abnormalities | 3 | 2026 | 16 | 1.020 |
Why?
| | Tooth Injuries | 3 | 2025 | 9 | 0.950 |
Why?
| | Precancerous Conditions | 6 | 2013 | 166 | 0.930 |
Why?
| | Tooth, Supernumerary | 2 | 2025 | 5 | 0.930 |
Why?
| | AIDS-Related Opportunistic Infections | 15 | 2005 | 130 | 0.900 |
Why?
| | Tooth, Deciduous | 12 | 2006 | 19 | 0.860 |
Why?
| | Carcinoma, Squamous Cell | 11 | 2013 | 641 | 0.860 |
Why?
| | Tooth Remineralization | 8 | 2007 | 12 | 0.860 |
Why?
| | Lip Diseases | 6 | 2013 | 7 | 0.850 |
Why?
| | Ethics, Dental | 3 | 2013 | 3 | 0.830 |
Why?
| | Molar | 22 | 2014 | 47 | 0.810 |
Why?
| | Mandibular Diseases | 7 | 2007 | 11 | 0.810 |
Why?
| | Pit and Fissure Sealants | 10 | 2007 | 19 | 0.810 |
Why?
| | Lichen Planus, Oral | 4 | 2013 | 5 | 0.810 |
Why?
| | Humans | 231 | 2026 | 145474 | 0.680 |
Why?
| | Tooth Root | 11 | 2026 | 21 | 0.680 |
Why?
| | Gingival Neoplasms | 5 | 2001 | 10 | 0.650 |
Why?
| | HIV Infections | 31 | 2013 | 3193 | 0.630 |
Why?
| | Gingiva | 4 | 2012 | 25 | 0.620 |
Why?
| | Condylomata Acuminata | 3 | 2013 | 7 | 0.590 |
Why?
| | Child | 59 | 2026 | 22707 | 0.580 |
Why?
| | Composite Resins | 10 | 2010 | 106 | 0.570 |
Why?
| | Odontogenic Tumors | 6 | 2001 | 9 | 0.560 |
Why?
| | Glossitis | 3 | 2003 | 3 | 0.530 |
Why?
| | Burns, Chemical | 2 | 2012 | 33 | 0.510 |
Why?
| | Fluorides, Topical | 9 | 2004 | 16 | 0.500 |
Why?
| | Sarcoma, Kaposi | 8 | 2002 | 83 | 0.490 |
Why?
| | Male | 95 | 2026 | 72842 | 0.490 |
Why?
| | Drugs, Chinese Herbal | 1 | 2016 | 24 | 0.460 |
Why?
| | Resin Cements | 8 | 2010 | 24 | 0.460 |
Why?
| | Tongue | 7 | 2004 | 76 | 0.460 |
Why?
| | Candidiasis, Oral | 13 | 2007 | 19 | 0.450 |
Why?
| | Saliva | 8 | 2003 | 246 | 0.440 |
Why?
| | Maxillary Diseases | 4 | 2012 | 7 | 0.430 |
Why?
| | Laser Therapy | 12 | 2006 | 144 | 0.430 |
Why?
| | Radiography | 19 | 2007 | 852 | 0.420 |
Why?
| | Acidulated Phosphate Fluoride | 12 | 2007 | 12 | 0.420 |
Why?
| | Dental Bonding | 6 | 2010 | 28 | 0.420 |
Why?
| | Dental Sac | 1 | 2014 | 1 | 0.410 |
Why?
| | Gingival Hypertrophy | 1 | 2014 | 1 | 0.410 |
Why?
| | Analysis of Variance | 24 | 2007 | 1300 | 0.410 |
Why?
| | Root Caries | 9 | 2014 | 10 | 0.400 |
Why?
| | Mouth Floor | 4 | 2001 | 7 | 0.400 |
Why?
| | Herpesvirus 4, Human | 9 | 2007 | 172 | 0.400 |
Why?
| | Dental Plaque | 6 | 2004 | 19 | 0.400 |
Why?
| | Child, Preschool | 33 | 2026 | 11853 | 0.390 |
Why?
| | Female | 78 | 2026 | 78844 | 0.390 |
Why?
| | Microscopy, Polarization | 17 | 2013 | 30 | 0.380 |
Why?
| | Granular Cell Tumor | 2 | 2003 | 8 | 0.380 |
Why?
| | Lasers | 7 | 2004 | 126 | 0.380 |
Why?
| | Mandible | 6 | 2026 | 73 | 0.380 |
Why?
| | Carcinoma, Mucoepidermoid | 4 | 2000 | 17 | 0.370 |
Why?
| | Oral Ulcer | 8 | 2003 | 11 | 0.370 |
Why?
| | Glass Ionomer Cements | 6 | 2003 | 8 | 0.370 |
Why?
| | Salivary Gland Neoplasms | 4 | 2000 | 39 | 0.360 |
Why?
| | Odontogenic Cysts | 1 | 2012 | 1 | 0.360 |
Why?
| | Dentifrices | 3 | 2014 | 5 | 0.360 |
Why?
| | Purpura | 1 | 2012 | 18 | 0.360 |
Why?
| | Leukoplakia, Hairy | 8 | 2004 | 8 | 0.350 |
Why?
| | Head and Neck Neoplasms | 4 | 2002 | 561 | 0.350 |
Why?
| | Ethics, Professional | 1 | 2011 | 14 | 0.350 |
Why?
| | Jaw Diseases | 2 | 2005 | 5 | 0.340 |
Why?
| | Gingivitis | 2 | 2010 | 13 | 0.340 |
Why?
| | Tooth Diseases | 2 | 2001 | 13 | 0.340 |
Why?
| | Palatal Neoplasms | 2 | 2001 | 6 | 0.330 |
Why?
| | Gingival Hyperplasia | 1 | 2010 | 3 | 0.330 |
Why?
| | Cheek | 2 | 2000 | 16 | 0.320 |
Why?
| | Dental Cavity Preparation | 7 | 2003 | 7 | 0.320 |
Why?
| | Gingivitis, Necrotizing Ulcerative | 5 | 2003 | 5 | 0.320 |
Why?
| | Sodium Fluoride | 8 | 2013 | 15 | 0.320 |
Why?
| | HIV Seropositivity | 4 | 2007 | 119 | 0.320 |
Why?
| | Lithiasis | 1 | 2009 | 3 | 0.310 |
Why?
| | Fibroma, Ossifying | 3 | 2001 | 3 | 0.310 |
Why?
| | Tooth Eruption | 5 | 2014 | 10 | 0.310 |
Why?
| | Pharyngeal Diseases | 1 | 2009 | 17 | 0.310 |
Why?
| | Schools, Dental | 2 | 2011 | 14 | 0.310 |
Why?
| | Leukoplakia, Oral | 3 | 2011 | 8 | 0.300 |
Why?
| | Palatine Tonsil | 1 | 2009 | 54 | 0.300 |
Why?
| | Cysts | 3 | 2002 | 112 | 0.290 |
Why?
| | Teaching | 1 | 2011 | 237 | 0.280 |
Why?
| | Glossitis, Benign Migratory | 3 | 2010 | 5 | 0.280 |
Why?
| | Academic Medical Centers | 2 | 2011 | 554 | 0.280 |
Why?
| | Immunocompromised Host | 6 | 2013 | 202 | 0.280 |
Why?
| | Anesthesia, Dental | 5 | 2014 | 21 | 0.280 |
Why?
| | Alveolar Bone Loss | 2 | 2007 | 9 | 0.270 |
Why?
| | Adult | 55 | 2013 | 40777 | 0.270 |
Why?
| | Epithelium | 9 | 2012 | 310 | 0.270 |
Why?
| | Stomatitis, Herpetic | 4 | 2001 | 5 | 0.270 |
Why?
| | Acyclovir | 6 | 2004 | 98 | 0.270 |
Why?
| | Histiocytosis, Langerhans-Cell | 2 | 2005 | 36 | 0.270 |
Why?
| | Salivary Gland Calculi | 2 | 2000 | 3 | 0.270 |
Why?
| | Dental Care for Chronically Ill | 5 | 2006 | 10 | 0.270 |
Why?
| | Dental Materials | 3 | 2003 | 56 | 0.260 |
Why?
| | Tooth Demineralization | 8 | 2013 | 10 | 0.260 |
Why?
| | Acquired Immunodeficiency Syndrome | 4 | 2001 | 237 | 0.260 |
Why?
| | Acid Etching, Dental | 7 | 2001 | 12 | 0.260 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2011 | 337 | 0.260 |
Why?
| | Tooth Extraction | 3 | 2025 | 28 | 0.260 |
Why?
| | Denture, Complete, Lower | 1 | 2007 | 1 | 0.250 |
Why?
| | Dental Implantation, Endosseous | 1 | 2007 | 3 | 0.250 |
Why?
| | Learning | 1 | 2011 | 443 | 0.250 |
Why?
| | Dental Prosthesis, Implant-Supported | 1 | 2007 | 7 | 0.250 |
Why?
| | Maxillary Neoplasms | 4 | 1995 | 8 | 0.250 |
Why?
| | Zirconium | 3 | 2001 | 12 | 0.250 |
Why?
| | Dental Implants | 1 | 2007 | 10 | 0.250 |
Why?
| | Gingival Overgrowth | 3 | 2003 | 5 | 0.250 |
Why?
| | Papillomavirus Infections | 3 | 2013 | 344 | 0.240 |
Why?
| | Middle Aged | 41 | 2013 | 36215 | 0.240 |
Why?
| | Saliva, Artificial | 9 | 2014 | 11 | 0.240 |
Why?
| | Valine | 5 | 2004 | 83 | 0.240 |
Why?
| | Dentists | 3 | 2001 | 21 | 0.240 |
Why?
| | Tooth, Unerupted | 2 | 2002 | 2 | 0.240 |
Why?
| | Tooth, Impacted | 3 | 2003 | 8 | 0.240 |
Why?
| | Biopsy | 8 | 2012 | 1082 | 0.240 |
Why?
| | Adolescent | 31 | 2025 | 22529 | 0.240 |
Why?
| | Radiography, Panoramic | 1 | 2026 | 14 | 0.240 |
Why?
| | Dental Enamel Solubility | 5 | 2006 | 5 | 0.230 |
Why?
| | Maxilla | 7 | 2002 | 36 | 0.230 |
Why?
| | Texas | 8 | 2017 | 272 | 0.230 |
Why?
| | Tooth Fractures | 1 | 2025 | 7 | 0.230 |
Why?
| | Epstein-Barr Virus Infections | 5 | 2007 | 101 | 0.230 |
Why?
| | Molluscum Contagiosum | 2 | 2002 | 4 | 0.230 |
Why?
| | Silicon Dioxide | 3 | 2001 | 119 | 0.230 |
Why?
| | Sarcoidosis | 1 | 2007 | 163 | 0.230 |
Why?
| | Dental Caries Susceptibility | 11 | 2006 | 11 | 0.230 |
Why?
| | Dental Research | 1 | 2005 | 4 | 0.220 |
Why?
| | Tuberculosis, Lymph Node | 1 | 2005 | 7 | 0.220 |
Why?
| | Odontoma | 2 | 2003 | 4 | 0.220 |
Why?
| | Cuspid | 2 | 2002 | 9 | 0.220 |
Why?
| | Cytodiagnosis | 4 | 2012 | 31 | 0.220 |
Why?
| | Dentist-Patient Relations | 3 | 2013 | 6 | 0.220 |
Why?
| | Microscopy, Electron, Scanning | 15 | 2003 | 196 | 0.220 |
Why?
| | Blister | 2 | 2001 | 39 | 0.210 |
Why?
| | Lymphocele | 1 | 2004 | 2 | 0.210 |
Why?
| | Compomers | 2 | 2003 | 2 | 0.210 |
Why?
| | Tongue Diseases | 1 | 2004 | 9 | 0.210 |
Why?
| | Mucocele | 2 | 2001 | 12 | 0.210 |
Why?
| | Hemangioma | 2 | 2002 | 46 | 0.210 |
Why?
| | Calcium Phosphates | 2 | 2004 | 28 | 0.210 |
Why?
| | Warts | 2 | 2001 | 6 | 0.200 |
Why?
| | Root Resorption | 3 | 2006 | 4 | 0.200 |
Why?
| | Lymphoma, AIDS-Related | 2 | 2002 | 14 | 0.200 |
Why?
| | Calcium | 5 | 2007 | 1190 | 0.200 |
Why?
| | Argon | 16 | 2004 | 21 | 0.200 |
Why?
| | Prevalence | 7 | 2026 | 2865 | 0.200 |
Why?
| | Hyperplasia | 5 | 2003 | 177 | 0.200 |
Why?
| | Lymphatic Diseases | 2 | 2002 | 21 | 0.200 |
Why?
| | Granuloma, Giant Cell | 2 | 2000 | 4 | 0.200 |
Why?
| | Erythema | 2 | 2001 | 28 | 0.200 |
Why?
| | Bites, Human | 2 | 2014 | 3 | 0.190 |
Why?
| | Dental Amalgam | 1 | 2002 | 2 | 0.190 |
Why?
| | Cytomegalovirus Infections | 2 | 1996 | 206 | 0.190 |
Why?
| | Prognosis | 12 | 2002 | 4316 | 0.190 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 2002 | 6 | 0.190 |
Why?
| | Follow-Up Studies | 7 | 2025 | 5423 | 0.180 |
Why?
| | Universities | 1 | 2005 | 445 | 0.180 |
Why?
| | Parotitis | 2 | 2003 | 6 | 0.180 |
Why?
| | Lip Neoplasms | 1 | 2002 | 2 | 0.180 |
Why?
| | Crowns | 1 | 2002 | 2 | 0.180 |
Why?
| | Germinal Center | 1 | 2002 | 64 | 0.180 |
Why?
| | Cheilitis | 2 | 2003 | 3 | 0.180 |
Why?
| | Toothpastes | 2 | 2000 | 6 | 0.180 |
Why?
| | Sialadenitis | 1 | 2001 | 1 | 0.180 |
Why?
| | Sublingual Gland | 1 | 2001 | 1 | 0.180 |
Why?
| | Disease Progression | 6 | 2013 | 2864 | 0.180 |
Why?
| | Personal Autonomy | 2 | 2013 | 59 | 0.180 |
Why?
| | Cyclosporine | 1 | 2003 | 256 | 0.180 |
Why?
| | Salivary Glands, Minor | 2 | 2000 | 10 | 0.170 |
Why?
| | Nevus, Blue | 1 | 2001 | 2 | 0.170 |
Why?
| | Diazepam | 3 | 1986 | 33 | 0.170 |
Why?
| | Rhabdomyosarcoma | 1 | 2002 | 65 | 0.170 |
Why?
| | Evidence-Based Dentistry | 2 | 2012 | 6 | 0.170 |
Why?
| | Fibroma | 1 | 2001 | 21 | 0.170 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2013 | 279 | 0.170 |
Why?
| | Light | 6 | 2012 | 403 | 0.170 |
Why?
| | Pediatric Dentistry | 3 | 2001 | 12 | 0.170 |
Why?
| | Durapatite | 2 | 2004 | 37 | 0.170 |
Why?
| | Sjogren's Syndrome | 1 | 2001 | 37 | 0.160 |
Why?
| | Lip | 2 | 2000 | 23 | 0.160 |
Why?
| | Burkitt Lymphoma | 1 | 2001 | 61 | 0.160 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 838 | 0.160 |
Why?
| | Dental Care for Children | 2 | 1999 | 12 | 0.160 |
Why?
| | Neuroma | 1 | 2000 | 5 | 0.160 |
Why?
| | Resins, Synthetic | 1 | 2000 | 14 | 0.160 |
Why?
| | Malpractice | 1 | 2001 | 44 | 0.160 |
Why?
| | Neoplasms, Second Primary | 1 | 2002 | 102 | 0.160 |
Why?
| | Sunlight | 1 | 2001 | 78 | 0.160 |
Why?
| | Candida | 4 | 2006 | 45 | 0.160 |
Why?
| | Palate, Hard | 1 | 2000 | 5 | 0.160 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2001 | 100 | 0.160 |
Why?
| | Hair Dyes | 1 | 2000 | 15 | 0.160 |
Why?
| | Focal Epithelial Hyperplasia | 1 | 2000 | 1 | 0.160 |
Why?
| | Lymphangioma | 1 | 2000 | 9 | 0.160 |
Why?
| | Calcinosis | 1 | 2002 | 234 | 0.160 |
Why?
| | Lipoma | 1 | 2000 | 17 | 0.150 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2000 | 52 | 0.150 |
Why?
| | Herpesvirus 8, Human | 2 | 1997 | 67 | 0.150 |
Why?
| | Mineral Waters | 2 | 1989 | 2 | 0.150 |
Why?
| | Child Behavior | 3 | 2014 | 236 | 0.150 |
Why?
| | Virus Replication | 6 | 2007 | 521 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2011 | 1149 | 0.150 |
Why?
| | Food Hypersensitivity | 1 | 2001 | 164 | 0.150 |
Why?
| | Biomarkers, Tumor | 4 | 2004 | 1321 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2014 | 531 | 0.140 |
Why?
| | Attitude to Health | 2 | 2013 | 430 | 0.140 |
Why?
| | Oncogenic Viruses | 1 | 1998 | 3 | 0.140 |
Why?
| | Candidiasis | 1 | 1999 | 64 | 0.140 |
Why?
| | Vinblastine | 3 | 1995 | 75 | 0.140 |
Why?
| | Surface Properties | 8 | 2003 | 386 | 0.140 |
Why?
| | Self-Injurious Behavior | 1 | 2000 | 141 | 0.140 |
Why?
| | Facial Dermatoses | 3 | 2008 | 17 | 0.140 |
Why?
| | Statistics, Nonparametric | 7 | 2007 | 428 | 0.140 |
Why?
| | Dens in Dente | 2 | 1990 | 2 | 0.140 |
Why?
| | Osteoradionecrosis | 1 | 1998 | 4 | 0.140 |
Why?
| | Recurrence | 6 | 2003 | 1138 | 0.140 |
Why?
| | Nose Diseases | 1 | 1998 | 17 | 0.130 |
Why?
| | Pulpotomy | 2 | 1989 | 3 | 0.130 |
Why?
| | Myxoma | 1 | 1997 | 11 | 0.130 |
Why?
| | Palate | 1 | 1998 | 40 | 0.130 |
Why?
| | X-Ray Film | 2 | 1987 | 5 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2013 | 1747 | 0.130 |
Why?
| | Periodontal Diseases | 3 | 2007 | 62 | 0.130 |
Why?
| | Bicuspid | 5 | 2001 | 14 | 0.130 |
Why?
| | Dentin-Bonding Agents | 4 | 2003 | 14 | 0.120 |
Why?
| | Specimen Handling | 1 | 1998 | 182 | 0.120 |
Why?
| | Taste Buds | 1 | 1999 | 214 | 0.120 |
Why?
| | Cleft Lip | 1 | 2017 | 73 | 0.120 |
Why?
| | Xylitol | 2 | 2014 | 4 | 0.120 |
Why?
| | Tooth Bleaching | 1 | 1996 | 3 | 0.120 |
Why?
| | Peroxides | 1 | 1996 | 17 | 0.120 |
Why?
| | Melanoma | 2 | 2000 | 759 | 0.120 |
Why?
| | Cooperative Behavior | 4 | 2011 | 462 | 0.120 |
Why?
| | Cleft Palate | 1 | 2017 | 91 | 0.120 |
Why?
| | Ameloblastoma | 2 | 1993 | 5 | 0.120 |
Why?
| | Acids | 2 | 2012 | 17 | 0.120 |
Why?
| | Chronic Disease | 2 | 2018 | 1808 | 0.120 |
Why?
| | Ulcer | 1 | 1996 | 37 | 0.120 |
Why?
| | Anesthesia, Rectal | 2 | 1985 | 2 | 0.120 |
Why?
| | Secondary Prevention | 3 | 2002 | 251 | 0.120 |
Why?
| | Langerhans Cells | 2 | 2007 | 12 | 0.120 |
Why?
| | Cross-Sectional Studies | 3 | 2026 | 5904 | 0.120 |
Why?
| | Urea | 1 | 1996 | 85 | 0.120 |
Why?
| | HIV Seronegativity | 4 | 2007 | 29 | 0.120 |
Why?
| | Jaw Neoplasms | 1 | 1995 | 3 | 0.110 |
Why?
| | Acculturation | 1 | 2016 | 55 | 0.110 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 1995 | 7 | 0.110 |
Why?
| | Statistics as Topic | 5 | 2001 | 283 | 0.110 |
Why?
| | Retrospective Studies | 9 | 2026 | 17291 | 0.110 |
Why?
| | Age Factors | 6 | 2016 | 3342 | 0.110 |
Why?
| | Osteomyelitis | 2 | 2000 | 145 | 0.110 |
Why?
| | Sex Factors | 4 | 2016 | 2105 | 0.110 |
Why?
| | Orthodontic Brackets | 3 | 2010 | 15 | 0.110 |
Why?
| | Infant | 11 | 2002 | 10077 | 0.110 |
Why?
| | Phosphates | 4 | 2013 | 177 | 0.110 |
Why?
| | Tooth Eruption, Ectopic | 2 | 2003 | 2 | 0.110 |
Why?
| | Gingival Hemorrhage | 1 | 2014 | 1 | 0.100 |
Why?
| | Hernia | 1 | 2014 | 10 | 0.100 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 3 | 2000 | 53 | 0.100 |
Why?
| | Apatites | 2 | 2004 | 4 | 0.100 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 1995 | 178 | 0.100 |
Why?
| | Diastema | 1 | 1993 | 3 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2001 | 849 | 0.100 |
Why?
| | Fat Necrosis | 1 | 1993 | 12 | 0.100 |
Why?
| | Hypercalcemia | 1 | 1993 | 22 | 0.100 |
Why?
| | Papillomaviridae | 3 | 2000 | 116 | 0.100 |
Why?
| | Risk Factors | 10 | 2018 | 10885 | 0.100 |
Why?
| | Epithelial Cells | 4 | 2007 | 1131 | 0.100 |
Why?
| | Aurothioglucose | 1 | 1993 | 4 | 0.100 |
Why?
| | Lichen Planus | 1 | 1993 | 3 | 0.100 |
Why?
| | Chromosome Aberrations | 2 | 2005 | 166 | 0.100 |
Why?
| | Thermodynamics | 5 | 2001 | 419 | 0.100 |
Why?
| | Keratosis | 2 | 2003 | 16 | 0.090 |
Why?
| | Human papillomavirus 16 | 1 | 2013 | 27 | 0.090 |
Why?
| | Low-Level Light Therapy | 2 | 2004 | 7 | 0.090 |
Why?
| | Acrylic Resins | 3 | 2007 | 46 | 0.090 |
Why?
| | Antiviral Agents | 6 | 2004 | 769 | 0.090 |
Why?
| | DMF Index | 5 | 2003 | 18 | 0.090 |
Why?
| | Mass Screening | 2 | 2012 | 1360 | 0.090 |
Why?
| | Cariogenic Agents | 2 | 2014 | 2 | 0.090 |
Why?
| | Tooth Erosion | 1 | 2012 | 3 | 0.090 |
Why?
| | Hypnotics and Sedatives | 1 | 2014 | 222 | 0.090 |
Why?
| | Candy | 1 | 2012 | 5 | 0.090 |
Why?
| | Wound Healing | 2 | 2005 | 355 | 0.090 |
Why?
| | Dentin | 5 | 2001 | 22 | 0.090 |
Why?
| | Adolescent Behavior | 2 | 2002 | 494 | 0.090 |
Why?
| | Moral Development | 1 | 2011 | 2 | 0.090 |
Why?
| | Schools, Health Occupations | 1 | 2011 | 8 | 0.090 |
Why?
| | Simplexvirus | 3 | 1998 | 82 | 0.090 |
Why?
| | Curriculum | 2 | 2011 | 1070 | 0.090 |
Why?
| | Dental Hygienists | 1 | 2011 | 14 | 0.090 |
Why?
| | Administrative Personnel | 1 | 2011 | 33 | 0.090 |
Why?
| | Bioethical Issues | 1 | 2011 | 8 | 0.090 |
Why?
| | Keratins | 1 | 2012 | 171 | 0.090 |
Why?
| | Organizational Objectives | 1 | 2011 | 67 | 0.080 |
Why?
| | Dental Cavity Lining | 2 | 2002 | 2 | 0.080 |
Why?
| | General Practice, Dental | 3 | 2006 | 6 | 0.080 |
Why?
| | Dental Alloys | 3 | 2002 | 5 | 0.080 |
Why?
| | Alphapapillomavirus | 1 | 2011 | 35 | 0.080 |
Why?
| | Immunohistochemistry | 5 | 2003 | 1716 | 0.080 |
Why?
| | Stomatitis, Aphthous | 2 | 2001 | 9 | 0.080 |
Why?
| | Granuloma, Pyogenic | 2 | 2001 | 10 | 0.080 |
Why?
| | Organizational Innovation | 1 | 2011 | 119 | 0.080 |
Why?
| | Truth Disclosure | 1 | 2011 | 51 | 0.080 |
Why?
| | Professional Competence | 1 | 2011 | 91 | 0.080 |
Why?
| | Staff Development | 1 | 2011 | 63 | 0.080 |
Why?
| | DNA, Viral | 5 | 2004 | 356 | 0.080 |
Why?
| | Medical History Taking | 1 | 1991 | 117 | 0.080 |
Why?
| | Problem-Based Learning | 1 | 2011 | 97 | 0.080 |
Why?
| | Polyvinyls | 2 | 2007 | 19 | 0.080 |
Why?
| | Orthodontic Appliances | 2 | 2001 | 13 | 0.080 |
Why?
| | Faculty | 1 | 2011 | 147 | 0.080 |
Why?
| | Formocresols | 2 | 1989 | 2 | 0.080 |
Why?
| | Aged | 13 | 2012 | 26153 | 0.080 |
Why?
| | HIV-1 | 1 | 1996 | 908 | 0.080 |
Why?
| | Gingival Recession | 2 | 2007 | 6 | 0.080 |
Why?
| | Quality of Life | 2 | 2013 | 3204 | 0.080 |
Why?
| | Periapical Diseases | 1 | 1989 | 1 | 0.070 |
Why?
| | Pulpectomy | 1 | 1989 | 1 | 0.070 |
Why?
| | Choice Behavior | 1 | 2011 | 180 | 0.070 |
Why?
| | Dental Clinics | 2 | 2001 | 6 | 0.070 |
Why?
| | Collagen | 1 | 2012 | 457 | 0.070 |
Why?
| | Parents | 2 | 2016 | 1403 | 0.070 |
Why?
| | Cell Division | 3 | 2000 | 756 | 0.070 |
Why?
| | Program Development | 1 | 2011 | 368 | 0.070 |
Why?
| | Tin Fluorides | 2 | 1988 | 3 | 0.070 |
Why?
| | Gels | 3 | 2014 | 85 | 0.070 |
Why?
| | Water Supply | 1 | 1989 | 89 | 0.070 |
Why?
| | Proliferating Cell Nuclear Antigen | 2 | 2000 | 48 | 0.070 |
Why?
| | Infant, Newborn | 7 | 2002 | 6447 | 0.070 |
Why?
| | Nevus | 1 | 2008 | 26 | 0.070 |
Why?
| | Photomicrography | 2 | 2000 | 8 | 0.070 |
Why?
| | Porosity | 3 | 2003 | 94 | 0.070 |
Why?
| | Hamartoma | 1 | 2008 | 29 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 4 | 2006 | 280 | 0.070 |
Why?
| | Xerostomia | 3 | 2000 | 13 | 0.070 |
Why?
| | Vaccination | 1 | 1996 | 1426 | 0.070 |
Why?
| | Drug Combinations | 2 | 2001 | 396 | 0.070 |
Why?
| | In Vitro Techniques | 5 | 2002 | 1048 | 0.070 |
Why?
| | Radicular Cyst | 2 | 1998 | 2 | 0.070 |
Why?
| | Dental Restoration Failure | 2 | 2006 | 6 | 0.060 |
Why?
| | Viral Matrix Proteins | 3 | 2004 | 28 | 0.060 |
Why?
| | Denture, Overlay | 1 | 2007 | 6 | 0.060 |
Why?
| | Jaw, Edentulous | 1 | 2007 | 10 | 0.060 |
Why?
| | Dermatitis, Allergic Contact | 2 | 2000 | 73 | 0.060 |
Why?
| | Denture, Complete, Upper | 1 | 2006 | 2 | 0.060 |
Why?
| | Denture Bases | 1 | 2006 | 2 | 0.060 |
Why?
| | Chromium Alloys | 1 | 2006 | 4 | 0.060 |
Why?
| | Bone Marrow Transplantation | 1 | 1988 | 298 | 0.060 |
Why?
| | Tooth Mobility | 2 | 2006 | 5 | 0.060 |
Why?
| | Osseointegration | 1 | 2007 | 59 | 0.060 |
Why?
| | Dental Prophylaxis | 2 | 2003 | 6 | 0.060 |
Why?
| | Dental Cements | 2 | 2002 | 20 | 0.060 |
Why?
| | HIV | 3 | 1998 | 251 | 0.060 |
Why?
| | Practice Patterns, Dentists' | 1 | 2006 | 3 | 0.060 |
Why?
| | Root Canal Therapy | 1 | 2006 | 7 | 0.060 |
Why?
| | Root Canal Irrigants | 1 | 1986 | 3 | 0.060 |
Why?
| | Insurance Claim Reporting | 1 | 2006 | 26 | 0.060 |
Why?
| | Silicon | 1 | 2005 | 19 | 0.060 |
Why?
| | Patient Education as Topic | 1 | 2011 | 777 | 0.060 |
Why?
| | Prospective Studies | 6 | 2014 | 8057 | 0.060 |
Why?
| | Glass | 1 | 2005 | 46 | 0.060 |
Why?
| | Implants, Experimental | 1 | 2005 | 21 | 0.060 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2005 | 17 | 0.060 |
Why?
| | Regression Analysis | 2 | 2000 | 1001 | 0.060 |
Why?
| | Resins, Plant | 2 | 2002 | 5 | 0.060 |
Why?
| | Cytoplasmic Granules | 1 | 2005 | 60 | 0.060 |
Why?
| | Denture Design | 2 | 2006 | 4 | 0.060 |
Why?
| | Education, Dental | 1 | 2006 | 37 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 60 | 0.060 |
Why?
| | Biomedical and Dental Materials | 1 | 2005 | 1 | 0.060 |
Why?
| | Molar, Third | 1 | 1985 | 6 | 0.060 |
Why?
| | Neoplasm Staging | 4 | 2010 | 1471 | 0.060 |
Why?
| | Antigens, CD | 2 | 2002 | 558 | 0.060 |
Why?
| | Denture, Complete | 1 | 2005 | 7 | 0.060 |
Why?
| | Pathology, Oral | 1 | 2005 | 1 | 0.060 |
Why?
| | Ganciclovir | 2 | 1996 | 53 | 0.060 |
Why?
| | Antifungal Agents | 3 | 2005 | 151 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2017 | 3623 | 0.050 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2000 | 194 | 0.050 |
Why?
| | Malocclusion | 2 | 2001 | 22 | 0.050 |
Why?
| | Romania | 2 | 2003 | 12 | 0.050 |
Why?
| | Dental Pulp Necrosis | 2 | 2001 | 2 | 0.050 |
Why?
| | Chemokines, CC | 1 | 2004 | 33 | 0.050 |
Why?
| | Phosphoric Acids | 4 | 2001 | 14 | 0.050 |
Why?
| | Vocabulary, Controlled | 1 | 2005 | 47 | 0.050 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2004 | 12 | 0.050 |
Why?
| | Receptors, CCR5 | 1 | 2004 | 60 | 0.050 |
Why?
| | Burning Mouth Syndrome | 2 | 1996 | 5 | 0.050 |
Why?
| | Osteosarcoma | 2 | 1998 | 82 | 0.050 |
Why?
| | Treatment Outcome | 6 | 2007 | 11772 | 0.050 |
Why?
| | Lymphocytes | 2 | 2004 | 376 | 0.050 |
Why?
| | Dental Enamel Permeability | 1 | 2004 | 1 | 0.050 |
Why?
| | Halitosis | 1 | 2003 | 1 | 0.050 |
Why?
| | Neoplasm Invasiveness | 3 | 2000 | 506 | 0.050 |
Why?
| | Mental Recall | 1 | 1986 | 222 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 93 | 0.050 |
Why?
| | History, 20th Century | 1 | 2005 | 328 | 0.050 |
Why?
| | Acetates | 2 | 2001 | 78 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2002 | 305 | 0.050 |
Why?
| | Sex Distribution | 2 | 2002 | 387 | 0.050 |
Why?
| | Memory | 1 | 1986 | 295 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2004 | 779 | 0.050 |
Why?
| | Materials Testing | 4 | 2013 | 345 | 0.050 |
Why?
| | Lactobacillus | 1 | 2003 | 28 | 0.050 |
Why?
| | Streptococcus mutans | 1 | 2003 | 8 | 0.050 |
Why?
| | Connexins | 1 | 2003 | 54 | 0.050 |
Why?
| | Diet, Cariogenic | 1 | 2003 | 1 | 0.050 |
Why?
| | Secretory Rate | 1 | 2003 | 12 | 0.050 |
Why?
| | Dental Leakage | 1 | 2002 | 2 | 0.050 |
Why?
| | Lymphoma, B-Cell | 1 | 2004 | 140 | 0.050 |
Why?
| | Methacrylates | 2 | 2000 | 119 | 0.050 |
Why?
| | Reed-Sternberg Cells | 1 | 2002 | 3 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2003 | 73 | 0.050 |
Why?
| | Factor XIIa | 1 | 2002 | 2 | 0.050 |
Why?
| | S100 Proteins | 1 | 2002 | 35 | 0.050 |
Why?
| | Mentors | 1 | 2005 | 217 | 0.050 |
Why?
| | Mouthwashes | 3 | 2010 | 13 | 0.050 |
Why?
| | Polymerase Chain Reaction | 4 | 2003 | 1041 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2011 | 1146 | 0.050 |
Why?
| | Drug Resistance, Viral | 1 | 2003 | 126 | 0.050 |
Why?
| | Stem Cells | 1 | 2007 | 628 | 0.050 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 66 | 0.050 |
Why?
| | Lymphoma, Follicular | 1 | 2002 | 56 | 0.040 |
Why?
| | Decision Trees | 1 | 2002 | 78 | 0.040 |
Why?
| | Gold Alloys | 1 | 2002 | 1 | 0.040 |
Why?
| | Remission Induction | 1 | 2003 | 307 | 0.040 |
Why?
| | Cleidocranial Dysplasia | 1 | 2001 | 1 | 0.040 |
Why?
| | Combined Modality Therapy | 4 | 2004 | 1266 | 0.040 |
Why?
| | Sclerosis | 1 | 2001 | 11 | 0.040 |
Why?
| | Dental Service, Hospital | 1 | 2001 | 1 | 0.040 |
Why?
| | Cosmetic Techniques | 1 | 2002 | 18 | 0.040 |
Why?
| | Skin Diseases | 1 | 2003 | 152 | 0.040 |
Why?
| | Lactic Acid | 2 | 2014 | 295 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2003 | 335 | 0.040 |
Why?
| | Heart | 1 | 1985 | 626 | 0.040 |
Why?
| | Pericoronitis | 1 | 2001 | 1 | 0.040 |
Why?
| | Respiratory System Abnormalities | 1 | 2001 | 18 | 0.040 |
Why?
| | Microfilament Proteins | 1 | 2002 | 135 | 0.040 |
Why?
| | Caustics | 1 | 2001 | 6 | 0.040 |
Why?
| | 2-Propanol | 1 | 2001 | 20 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2005 | 429 | 0.040 |
Why?
| | Dental Enamel Hypoplasia | 1 | 1981 | 8 | 0.040 |
Why?
| | Hypoparathyroidism | 1 | 1981 | 7 | 0.040 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 318 | 0.040 |
Why?
| | Carcinoma, Verrucous | 1 | 2001 | 3 | 0.040 |
Why?
| | Dental High-Speed Equipment | 1 | 2001 | 1 | 0.040 |
Why?
| | Facial Neoplasms | 1 | 2001 | 19 | 0.040 |
Why?
| | alpha 1-Antitrypsin | 1 | 2002 | 104 | 0.040 |
Why?
| | Anti-Infective Agents, Local | 1 | 2001 | 40 | 0.040 |
Why?
| | Salivary Gland Diseases | 1 | 2001 | 1 | 0.040 |
Why?
| | Diet | 1 | 1989 | 1277 | 0.040 |
Why?
| | Fishes | 1 | 2001 | 109 | 0.040 |
Why?
| | AIDS Serodiagnosis | 1 | 2001 | 23 | 0.040 |
Why?
| | Melanocytes | 1 | 2001 | 65 | 0.040 |
Why?
| | Mandibular Nerve | 1 | 2000 | 5 | 0.040 |
Why?
| | Plasminogen | 1 | 2001 | 27 | 0.040 |
Why?
| | Folliculitis | 1 | 2000 | 1 | 0.040 |
Why?
| | Tooth Crown | 1 | 2000 | 2 | 0.040 |
Why?
| | Silicates | 1 | 2000 | 13 | 0.040 |
Why?
| | Liability, Legal | 1 | 2001 | 42 | 0.040 |
Why?
| | Denture, Partial, Removable | 1 | 2000 | 2 | 0.040 |
Why?
| | Time Factors | 8 | 2014 | 7123 | 0.040 |
Why?
| | Phenols | 1 | 2001 | 106 | 0.040 |
Why?
| | Nickel | 2 | 2006 | 62 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 1989 | 1419 | 0.040 |
Why?
| | Habits | 1 | 2000 | 52 | 0.040 |
Why?
| | Polymethacrylic Acids | 1 | 2000 | 61 | 0.040 |
Why?
| | Hodgkin Disease | 1 | 2002 | 171 | 0.040 |
Why?
| | Arthritis, Juvenile | 1 | 2001 | 60 | 0.040 |
Why?
| | Periodontitis | 1 | 2001 | 55 | 0.040 |
Why?
| | Smoking | 4 | 2012 | 1472 | 0.040 |
Why?
| | Diffusion | 1 | 2000 | 120 | 0.040 |
Why?
| | Alcohol Drinking | 4 | 2012 | 837 | 0.040 |
Why?
| | Emergencies | 1 | 2001 | 174 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2000 | 117 | 0.040 |
Why?
| | Silicic Acid | 1 | 2000 | 2 | 0.040 |
Why?
| | Hair | 1 | 2000 | 84 | 0.040 |
Why?
| | Complex Mixtures | 1 | 2000 | 11 | 0.040 |
Why?
| | Hyperpigmentation | 1 | 2000 | 27 | 0.040 |
Why?
| | Coloring Agents | 3 | 2012 | 89 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 158 | 0.040 |
Why?
| | Triclosan | 1 | 2000 | 9 | 0.040 |
Why?
| | Age Distribution | 3 | 2001 | 403 | 0.040 |
Why?
| | Cytomegalovirus | 2 | 1998 | 168 | 0.040 |
Why?
| | American Dental Association | 2 | 2012 | 6 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2001 | 335 | 0.040 |
Why?
| | Polymers | 2 | 2000 | 485 | 0.040 |
Why?
| | Models, Biological | 1 | 2007 | 1764 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2000 | 110 | 0.040 |
Why?
| | Survival Rate | 2 | 2002 | 2090 | 0.040 |
Why?
| | Graft Rejection | 1 | 2003 | 521 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2002 | 441 | 0.040 |
Why?
| | Nerve Block | 1 | 2000 | 107 | 0.040 |
Why?
| | Plasminogen Activators | 1 | 1998 | 7 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2004 | 777 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 165 | 0.040 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1998 | 25 | 0.040 |
Why?
| | Collagenases | 1 | 1998 | 22 | 0.040 |
Why?
| | Flavonoids | 1 | 1999 | 85 | 0.040 |
Why?
| | Herpesviridae | 1 | 1998 | 21 | 0.040 |
Why?
| | Vacuum | 1 | 1998 | 10 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2003 | 466 | 0.040 |
Why?
| | Injections, Intralesional | 2 | 1995 | 35 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2007 | 2046 | 0.040 |
Why?
| | Gram-Negative Anaerobic Cocci | 1 | 1998 | 1 | 0.040 |
Why?
| | Suction | 1 | 1998 | 32 | 0.030 |
Why?
| | Evaluation Studies as Topic | 2 | 1989 | 164 | 0.030 |
Why?
| | Equipment Design | 1 | 2000 | 525 | 0.030 |
Why?
| | Virus Shedding | 1 | 1998 | 49 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2002 | 728 | 0.030 |
Why?
| | Arteries | 1 | 2000 | 261 | 0.030 |
Why?
| | Bone Cysts | 1 | 1998 | 12 | 0.030 |
Why?
| | Periodontal Cyst | 1 | 1997 | 1 | 0.030 |
Why?
| | Fibrosarcoma | 1 | 1998 | 23 | 0.030 |
Why?
| | Eosinophilic Granuloma | 1 | 1997 | 3 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 288 | 0.030 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 1998 | 49 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 1999 | 203 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2001 | 484 | 0.030 |
Why?
| | Nose | 1 | 1998 | 67 | 0.030 |
Why?
| | Temperature | 1 | 2000 | 633 | 0.030 |
Why?
| | Motor Skills | 1 | 1998 | 104 | 0.030 |
Why?
| | Cytokines | 1 | 2005 | 2067 | 0.030 |
Why?
| | Oropharyngeal Neoplasms | 1 | 1998 | 56 | 0.030 |
Why?
| | Colony Count, Microbial | 3 | 2006 | 89 | 0.030 |
Why?
| | Incidence | 2 | 2012 | 2923 | 0.030 |
Why?
| | Survival Analysis | 1 | 2000 | 1374 | 0.030 |
Why?
| | Herpes Zoster | 1 | 2001 | 319 | 0.030 |
Why?
| | Molecular Sequence Data | 4 | 2004 | 2883 | 0.030 |
Why?
| | Periapical Granuloma | 1 | 1996 | 1 | 0.030 |
Why?
| | Radiotherapy | 1 | 1998 | 204 | 0.030 |
Why?
| | Dental Enamel Proteins | 1 | 1996 | 2 | 0.030 |
Why?
| | Role | 1 | 1996 | 28 | 0.030 |
Why?
| | Cryptococcosis | 1 | 1997 | 31 | 0.030 |
Why?
| | Digestive System | 1 | 1996 | 29 | 0.030 |
Why?
| | Growth Substances | 1 | 1996 | 138 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1996 | 16 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2003 | 712 | 0.030 |
Why?
| | Viral Proteins | 3 | 2004 | 350 | 0.030 |
Why?
| | Choristoma | 1 | 1996 | 20 | 0.030 |
Why?
| | United States | 5 | 2012 | 16098 | 0.030 |
Why?
| | Early Detection of Cancer | 2 | 2012 | 485 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 820 | 0.030 |
Why?
| | Carcinoma, Basosquamous | 1 | 1995 | 2 | 0.030 |
Why?
| | Sarcoma, Small Cell | 1 | 1995 | 2 | 0.030 |
Why?
| | Anti-HIV Agents | 2 | 2000 | 912 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1997 | 134 | 0.030 |
Why?
| | Placebos | 2 | 1986 | 193 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 1995 | 44 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1789 | 0.030 |
Why?
| | Cocarcinogenesis | 1 | 1995 | 13 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1996 | 188 | 0.030 |
Why?
| | Immunization Schedule | 1 | 1996 | 186 | 0.030 |
Why?
| | Virus Latency | 2 | 2007 | 90 | 0.030 |
Why?
| | Virus Activation | 2 | 2007 | 94 | 0.030 |
Why?
| | Hydroxyzine | 1 | 2014 | 3 | 0.030 |
Why?
| | Meperidine | 1 | 2014 | 6 | 0.030 |
Why?
| | Akathisia, Drug-Induced | 1 | 2014 | 5 | 0.030 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2014 | 14 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 36 | 0.030 |
Why?
| | Anesthesia Recovery Period | 1 | 2014 | 28 | 0.030 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2129 | 0.030 |
Why?
| | Pilot Projects | 3 | 2006 | 1891 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2001 | 867 | 0.030 |
Why?
| | Lupus Erythematosus, Discoid | 1 | 1994 | 5 | 0.030 |
Why?
| | Clobetasol | 1 | 1994 | 7 | 0.030 |
Why?
| | Genes, Viral | 2 | 2004 | 88 | 0.030 |
Why?
| | Neoplasms, Multiple Primary | 1 | 1995 | 58 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 696 | 0.030 |
Why?
| | Sleep Stages | 1 | 2014 | 76 | 0.030 |
Why?
| | Emergency Medical Services | 1 | 2001 | 684 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2000 | 8333 | 0.030 |
Why?
| | Midazolam | 1 | 2014 | 73 | 0.030 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2014 | 25 | 0.030 |
Why?
| | Adhesiveness | 1 | 1994 | 18 | 0.030 |
Why?
| | Psychomotor Agitation | 1 | 2014 | 69 | 0.030 |
Why?
| | Ketoconazole | 1 | 1993 | 3 | 0.030 |
Why?
| | Salivary Proteins and Peptides | 1 | 1993 | 14 | 0.030 |
Why?
| | Vomiting | 1 | 2014 | 131 | 0.020 |
Why?
| | Papillon-Lefevre Disease | 1 | 1993 | 1 | 0.020 |
Why?
| | Zidovudine | 1 | 1993 | 77 | 0.020 |
Why?
| | Awareness | 1 | 2014 | 110 | 0.020 |
Why?
| | Surface-Active Agents | 1 | 2014 | 98 | 0.020 |
Why?
| | Tooth Loss | 1 | 1993 | 27 | 0.020 |
Why?
| | Bacteria | 1 | 1998 | 765 | 0.020 |
Why?
| | Tolonium Chloride | 1 | 2012 | 4 | 0.020 |
Why?
| | Fibrous Dysplasia of Bone | 1 | 1991 | 5 | 0.020 |
Why?
| | Asymptomatic Diseases | 1 | 2012 | 104 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 1993 | 271 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2011 | 23 | 0.020 |
Why?
| | Control Groups | 1 | 2011 | 12 | 0.020 |
Why?
| | Dental Marginal Adaptation | 2 | 2003 | 10 | 0.020 |
Why?
| | Triamcinolone Acetonide | 1 | 1991 | 20 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1995 | 534 | 0.020 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 193 | 0.020 |
Why?
| | Physical Examination | 1 | 2012 | 243 | 0.020 |
Why?
| | Double-Blind Method | 2 | 1986 | 2062 | 0.020 |
Why?
| | Sarcoma, Ewing | 1 | 1991 | 103 | 0.020 |
Why?
| | Review Literature as Topic | 1 | 2010 | 52 | 0.020 |
Why?
| | Bias | 1 | 2011 | 197 | 0.020 |
Why?
| | Cell Adhesion | 2 | 2006 | 451 | 0.020 |
Why?
| | RNA, Viral | 2 | 2004 | 692 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 718 | 0.020 |
Why?
| | Zinc Oxide-Eugenol Cement | 1 | 1989 | 2 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2028 | 0.020 |
Why?
| | Animals | 5 | 2005 | 38030 | 0.020 |
Why?
| | Genotype | 2 | 2004 | 1852 | 0.020 |
Why?
| | Oral Hemorrhage | 2 | 2001 | 3 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 1999 | 131 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 1988 | 200 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 1998 | 414 | 0.020 |
Why?
| | Sweetening Agents | 1 | 1988 | 57 | 0.020 |
Why?
| | Mice, Nude | 2 | 1999 | 679 | 0.020 |
Why?
| | Sleep | 1 | 2014 | 888 | 0.020 |
Why?
| | Prosthodontics | 1 | 2006 | 1 | 0.010 |
Why?
| | Dentistry, Operative | 1 | 2006 | 4 | 0.010 |
Why?
| | Endodontics | 1 | 2006 | 4 | 0.010 |
Why?
| | Dental Fistula | 1 | 2006 | 1 | 0.010 |
Why?
| | Periapical Periodontitis | 1 | 2006 | 2 | 0.010 |
Why?
| | Suppositories | 1 | 1986 | 3 | 0.010 |
Why?
| | Preanesthetic Medication | 1 | 1986 | 6 | 0.010 |
Why?
| | Periodontics | 1 | 2006 | 10 | 0.010 |
Why?
| | Current Procedural Terminology | 1 | 2006 | 19 | 0.010 |
Why?
| | Flow Cytometry | 3 | 1995 | 1162 | 0.010 |
Why?
| | Fluorescent Dyes | 2 | 1998 | 333 | 0.010 |
Why?
| | Pharmaceutical Preparations | 1 | 1988 | 170 | 0.010 |
Why?
| | Anesthesia, Local | 1 | 1986 | 26 | 0.010 |
Why?
| | Amnesia | 1 | 1986 | 47 | 0.010 |
Why?
| | Cohort Studies | 2 | 2011 | 6013 | 0.010 |
Why?
| | Beryllium | 1 | 2006 | 161 | 0.010 |
Why?
| | Diagnosis, Oral | 1 | 2005 | 8 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 978 | 0.010 |
Why?
| | Drug Carriers | 1 | 2006 | 136 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 1963 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2005 | 335 | 0.010 |
Why?
| | Asthma | 1 | 1997 | 1797 | 0.010 |
Why?
| | Lung Neoplasms | 2 | 1995 | 2664 | 0.010 |
Why?
| | Immunoglobulin J-Chains | 1 | 2004 | 6 | 0.010 |
Why?
| | Lighting | 1 | 2004 | 31 | 0.010 |
Why?
| | Genes, Immunoglobulin | 1 | 2004 | 29 | 0.010 |
Why?
| | Sequence Analysis | 1 | 2004 | 34 | 0.010 |
Why?
| | Wettability | 1 | 2004 | 15 | 0.010 |
Why?
| | In Situ Hybridization | 2 | 1996 | 318 | 0.010 |
Why?
| | Rabbits | 1 | 2005 | 652 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2007 | 4148 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1997 | 2187 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2004 | 86 | 0.010 |
Why?
| | Molecular Epidemiology | 1 | 2004 | 73 | 0.010 |
Why?
| | Clone Cells | 1 | 2004 | 263 | 0.010 |
Why?
| | Connexin 26 | 1 | 2003 | 9 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1581 | 0.010 |
Why?
| | Sulfur Compounds | 1 | 2003 | 7 | 0.010 |
Why?
| | Dental Plaque Index | 1 | 2003 | 4 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 362 | 0.010 |
Why?
| | Periodontal Index | 1 | 2003 | 14 | 0.010 |
Why?
| | Mouth | 1 | 2004 | 86 | 0.010 |
Why?
| | Orthodontic Wires | 1 | 2003 | 6 | 0.010 |
Why?
| | Tooth Movement Techniques | 1 | 2003 | 13 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 2004 | 155 | 0.010 |
Why?
| | Genetic Markers | 1 | 2004 | 335 | 0.010 |
Why?
| | Cell Count | 1 | 2004 | 319 | 0.010 |
Why?
| | Breath Tests | 1 | 2003 | 77 | 0.010 |
Why?
| | Adhesives | 1 | 2003 | 15 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2004 | 2803 | 0.010 |
Why?
| | Observer Variation | 1 | 2003 | 357 | 0.010 |
Why?
| | Herpes Simplex | 1 | 2003 | 99 | 0.010 |
Why?
| | Colorado | 2 | 1990 | 4553 | 0.010 |
Why?
| | Stomatitis | 1 | 2002 | 15 | 0.010 |
Why?
| | Pigmentation Disorders | 1 | 2002 | 8 | 0.010 |
Why?
| | Longitudinal Studies | 2 | 2000 | 2953 | 0.010 |
Why?
| | Cell Movement | 1 | 2007 | 959 | 0.010 |
Why?
| | Color | 1 | 2002 | 81 | 0.010 |
Why?
| | Pigmentation | 1 | 2002 | 52 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 128 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2001 | 14 | 0.010 |
Why?
| | Toothache | 1 | 2001 | 5 | 0.010 |
Why?
| | Flatfoot | 1 | 2001 | 13 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2007 | 870 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2004 | 574 | 0.010 |
Why?
| | Blood Protein Disorders | 1 | 2001 | 1 | 0.010 |
Why?
| | Periapical Abscess | 1 | 2001 | 3 | 0.010 |
Why?
| | Erbium | 1 | 2001 | 4 | 0.010 |
Why?
| | Yttrium | 1 | 2001 | 5 | 0.010 |
Why?
| | Anti-Retroviral Agents | 1 | 2003 | 251 | 0.010 |
Why?
| | Washington | 1 | 2001 | 149 | 0.010 |
Why?
| | Aluminum Silicates | 1 | 2001 | 17 | 0.010 |
Why?
| | Dentition, Permanent | 1 | 2000 | 5 | 0.010 |
Why?
| | Conjunctivitis | 1 | 2001 | 30 | 0.010 |
Why?
| | Odds Ratio | 1 | 2003 | 1082 | 0.010 |
Why?
| | Staining and Labeling | 1 | 2001 | 153 | 0.010 |
Why?
| | Pedigree | 1 | 2001 | 515 | 0.010 |
Why?
| | Hemodynamics | 1 | 1985 | 1118 | 0.010 |
Why?
| | 1,2-Dipalmitoylphosphatidylcholine | 1 | 1999 | 11 | 0.010 |
Why?
| | Cesarean Section | 1 | 2001 | 230 | 0.010 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 1999 | 17 | 0.010 |
Why?
| | Mice | 3 | 2004 | 18329 | 0.010 |
Why?
| | Trans-Activators | 1 | 2001 | 396 | 0.010 |
Why?
| | Dentin Sensitivity | 1 | 1998 | 2 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 135 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2000 | 189 | 0.010 |
Why?
| | Scoliosis | 1 | 2001 | 221 | 0.010 |
Why?
| | Neck Muscles | 1 | 1998 | 21 | 0.010 |
Why?
| | Hematoxylin | 1 | 1998 | 8 | 0.010 |
Why?
| | Eosine Yellowish-(YS) | 1 | 1998 | 10 | 0.010 |
Why?
| | Methenamine | 1 | 1998 | 4 | 0.010 |
Why?
| | Decision Making | 1 | 2006 | 977 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1999 | 196 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 1998 | 246 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1998 | 146 | 0.010 |
Why?
| | Drug Resistance, Microbial | 1 | 1998 | 64 | 0.010 |
Why?
| | Logistic Models | 1 | 2003 | 2134 | 0.010 |
Why?
| | Point Mutation | 1 | 1999 | 240 | 0.010 |
Why?
| | Paraffin Embedding | 1 | 1998 | 33 | 0.010 |
Why?
| | Hearing Loss | 1 | 2001 | 249 | 0.010 |
Why?
| | Random Allocation | 1 | 1998 | 365 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2004 | 1454 | 0.010 |
Why?
| | Organic Chemicals | 1 | 1998 | 112 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1998 | 267 | 0.010 |
Why?
| | Mothers | 1 | 2003 | 765 | 0.010 |
Why?
| | Causalgia | 1 | 1996 | 1 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1998 | 886 | 0.010 |
Why?
| | Periodontal Ligament | 1 | 1996 | 3 | 0.010 |
Why?
| | Pneumonia, Pneumocystis | 1 | 1997 | 34 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1996 | 15 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1996 | 23 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 1998 | 527 | 0.010 |
Why?
| | Macrophages | 1 | 2004 | 1507 | 0.010 |
Why?
| | Substance Abuse, Intravenous | 1 | 1998 | 127 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1998 | 503 | 0.010 |
Why?
| | Tensile Strength | 1 | 1996 | 98 | 0.010 |
Why?
| | Syndrome | 1 | 1996 | 381 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 505 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 2597 | 0.010 |
Why?
| | Digestive System Surgical Procedures | 1 | 1996 | 112 | 0.010 |
Why?
| | Pharyngeal Neoplasms | 1 | 1995 | 4 | 0.010 |
Why?
| | Phylogeny | 1 | 1999 | 917 | 0.010 |
Why?
| | Translocation, Genetic | 1 | 1995 | 119 | 0.010 |
Why?
| | Denture, Partial | 1 | 1994 | 2 | 0.010 |
Why?
| | Dental Prosthesis | 1 | 1994 | 2 | 0.010 |
Why?
| | Laryngeal Neoplasms | 1 | 1995 | 36 | 0.010 |
Why?
| | Histological Techniques | 1 | 1994 | 39 | 0.010 |
Why?
| | Vincristine | 1 | 1995 | 142 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1480 | 0.010 |
Why?
| | Patch Tests | 1 | 1994 | 60 | 0.010 |
Why?
| | Algorithms | 1 | 2002 | 1845 | 0.010 |
Why?
| | Aneuploidy | 1 | 1994 | 91 | 0.010 |
Why?
| | Homosexuality | 1 | 1993 | 17 | 0.010 |
Why?
| | HIV Core Protein p24 | 1 | 1993 | 32 | 0.010 |
Why?
| | Ki-1 Antigen | 1 | 1993 | 7 | 0.010 |
Why?
| | Gold | 1 | 1994 | 116 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2004 | 5983 | 0.010 |
Why?
| | Bleomycin | 1 | 1995 | 255 | 0.010 |
Why?
| | Mucins | 1 | 1993 | 75 | 0.010 |
Why?
| | Inflammation | 1 | 2004 | 2878 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1993 | 114 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2170 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 316 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1998 | 1443 | 0.010 |
Why?
| | Cell Cycle | 1 | 1995 | 598 | 0.010 |
Why?
| | Phagocytosis | 1 | 1993 | 296 | 0.010 |
Why?
| | Cell Survival | 1 | 1993 | 1100 | 0.000 |
Why?
| | Pregnancy | 1 | 2001 | 7202 | 0.000 |
Why?
| | Saccharin | 1 | 1988 | 9 | 0.000 |
Why?
| | Tablets | 1 | 1988 | 41 | 0.000 |
Why?
| | DNA | 1 | 1994 | 1435 | 0.000 |
Why?
| | Theophylline | 1 | 1988 | 41 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1998 | 4560 | 0.000 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 6066 | 0.000 |
Why?
| | Solutions | 1 | 1988 | 159 | 0.000 |
Why?
| | Sucrose | 1 | 1988 | 114 | 0.000 |
Why?
| | Neutrophils | 1 | 1993 | 1124 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1996 | 2769 | 0.000 |
Why?
| | Anticonvulsants | 1 | 1988 | 246 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1988 | 1923 | 0.000 |
Why?
|
|
Flaitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|